Back to Search
Start Over
Overcoming
- Source :
- American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 42
- Publication Year :
- 2022
-
Abstract
- More than 50 years after the discovery of RAS family proteins, which harbor the most common activating mutations in cancer, the U.S. Food and Drug Administration approved the first direct allele-specific inhibitor of mutant
- Subjects :
- Proto-Oncogene Proteins p21(ras)
Lung Neoplasms
Mutation
Humans
Subjects
Details
- ISSN :
- 15488756
- Volume :
- 42
- Database :
- OpenAIRE
- Journal :
- American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
- Accession number :
- edsair.pmid..........fd7fbc41f5de34e481bbab8341081bb3